True 2 Beauty Appoints New CEO to Lead Global Branding of "Libigrow" Family of Products
October 14 2010 - 4:58AM
Marketwired
True 2 Beauty, Inc. (PINKSHEETS: TRTB) (the "Company"), a leading
manufacturer and distributor of male sexual potency pills and
liquid products in the United States, announced today the
appointment of Mr. Alex Hbaiu as President, CEO and Director.
Mr. Hbaiu has always enjoyed and found much success in
entrepreneurship. He is a graduate of the highly prestigious Milton
Hershey Boarding School.
Alex was provided a full academic scholarship to attend
Dickinson College where he studied Biochemistry and Economics. Mr.
Hbaiu has had several accomplishments while working for Eli Lily
Research Labs, publishing several research articles and findings
during his employment with the institute. Alex has had the
opportunity to work with some of the most talented and educated
doctors and scientists in the world.
The founder of Libigrow (www.libigrow.com), Mr. Hbaiu started
with very little capital and has led the growth to over $10,000,000
in sales by "word of mouth" advertising only.
Regarding this appointment Mr. Hbaiu stated, "I am honored to
accept this position and with the resources being provided by True
2 Beauty we are confident in ramping up our production quickly to
fill our growing order book as a result of our very successful
debut at the National Association of Convenience Stores (NACS)
trade show in Atlanta last week."
About True 2 Beauty, Inc.
True 2 Beauty, Inc. is a leading manufacturer and distributor of
male sexual potency pills and liquid products in the United States.
The True 2 Beauty, Inc. line of current products includes Libigrow,
Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink.
More information on the Company and its line of products can be
found at www.libigrow.com.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, among others, all assumptions,
expectations, predictions, intentions or beliefs about future
events. You are cautioned that any such forward-looking statements
are not guarantees of future performance and that a number of risks
and uncertainties could cause actual results of the Company to
differ materially from those anticipated, expressed or implied in
the forward-looking statements. The words "believe," "expect,"
"anticipate," "project," "targets," "optimistic," "intend," "aim,"
"will" or similar expressions are intended to identify
forward-looking statements. All statements other than statements of
historical fact are statements that could be deemed forward-looking
statements. Risks and uncertainties that could cause actual results
to differ materially from those anticipated include risks related
to new and existing products, product defects and any related
product recall; any projections of sales, earnings, revenue,
margins or other financial items; any statements of the plans,
strategies and objectives of management for future operations; any
statements. The Company assumes no obligation and does not intend
to update any forward-looking statements, except as required by
law.
For further information, please contact: Investors Relations
Contact: New York World Asset Management (702) 436-4562 Media
Relations: Zara Hbaiu zara@libigrow.com 1-888-942-5350
(USOTC:LEGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(USOTC:LEGX)
Historical Stock Chart
From Jul 2023 to Jul 2024